INS and cancer: The activation of IGF-1R by insulin triggers several signaling pathway, including PI3K/AKT, MAPK, JAK/STAT, Sarcoma (Src), and focal adhesion kinase (FAK), all of which collectively enhance cancer cell proliferation, survival, and migration (25).